The market came under pressure this week following Fed Chair Jerome Powell’s comments about inflation that were less than enthusiastic. While speaking at a policy forum focused on US-Canada economic relations, Powell articulated that the first quarter’s sticky inflation data means market-rate cuts will happen later than initially hoped. The Fed’s benchmark interest rate [...]
Monday was momentous because of the eclipse boosting hopes and dreams of disinflation, and Wednesday started with a downer because of higher-than-expected CPI data. The inflationary data came in hot, with every reading coming in above estimates, sending the market into a significant dip. Let’s dive into anticipation, the reaction, what it means, and [...]
The beginning of quarter 2 feels like April Fools keeps going with the markets under pressure due to the Fed’s hesitancy to cut rates, global strife continuing, and Tesla’s (TSLA) poor deliveries dragging the market down. Although delayed rate cuts are disappointing, seeing one of the magnificent 7 continue to plummet hurts like more [...]
Merck (MRK) received US FDA approval on Tuesday after the market’s close for Winrevair to treat pulmonary arterial hypertension (PAH), causing the stock to climb 4.6% pre-market. The company’s market cap is around $332.7 billion, indicating any notable movement is a result of a significant event, so the approval demonstrates a pretty big win [...]
The week, and, frankly, the month’s sentiment, will be set by today and tomorrow's Fed meeting and information on a rate cut. As Americans continue to feel inflationary pressures, the FOMC members’ interpretation of recent inflation data, such as CPI and PPI, will lay the path for when to expect a cut and how [...]
The week started off weak, turning green, and then shifted to mixed due to disappointing data, biotech success, uncertainty in tech, and tension in the US steel market. Monday showed mixed market results, Tuesday was in the green, investors proved unbothered on Wednesday after unfavorable CPI data, and the rest of the week looks [...]
Day-to-day market observations can be exhausting when the markets were red on March 5th, then extend significant gains in the early session on March 6th. The losses experienced yesterday can be attributed to Apple and Tesla’s disappointing news alongside mixed data from the US. Although the US market has seen extended gains in the [...]
A data-driven week means it’s time for a refresher on what could be the biggest market mover for February, also known as PCE data. The PCE (Personal Consumer Expenditures) is the Fed’s preferred inflation measurement because it gives a peak into consumers' saving and spending habits. Wednesday, February 28th, the preliminary Core PCE was [...]
If you’re wondering what’s contributing to the volatility in the market, it’s more than just inflation data, geopolitical events, or tech domination; a macro impacter for the market is earnings season! With Home Depot reporting lower-than-expected numbers and investors waiting for Nvidia’s report pessimistically, earnings season is hitting the markets with a baseball bat. [...]
Tuesday was record-breaking for the major dip due to key inflation data showing consumers are hurting over price increases. After Monday’s record-breaking numbers because of tech stocks and positive earnings, it was a surprise to find the market again in bear territory. The dip came because January CPI was reported M/M at 0.3% vs. [...]
